BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3247701)

  • 1. [Study of the "dawn phenomenon" using an artificial endocrine pancreas].
    Khristov V; Petkova M; Tsanev A
    Vutr Boles; 1988; 27(6):35-8. PubMed ID: 3247701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of biostator control on levels of contra-insulin hormones].
    Petkova M; Khristov V; Zlateva S; Tsanev A
    Vutr Boles; 1988; 27(3):61-4. PubMed ID: 3206905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
    Rodríguez García MA; Gutiérrez López MA; Durán García S
    Med Clin (Barc); 1988 Jun; 91(3):81-2. PubMed ID: 3050312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon].
    Consoli A; Capani F; Vitacolonna E; Sensi S
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1685-9. PubMed ID: 6395872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic changes in the hemostatic indices of diabetics during biostator control].
    Petkova M; Kamenov V; Tsanev A
    Vutr Boles; 1989; 28(5):41-5. PubMed ID: 2482584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dawn or Somogyi phenomenon? High morning fasting blood sugar values in young type-1 diabetics].
    Holl RW; Heinze E
    Dtsch Med Wochenschr; 1992 Oct; 117(40):1503-7. PubMed ID: 1396135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dawn phenomenon in diabetic pregnancy].
    Fernández I; Costa CJ; Rodríguez MA; Gutiérrez A; Griera JL; Durán García S
    Med Clin (Barc); 1990 Jan; 94(2):46-8. PubMed ID: 2184290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetes.
    Capaldo B; Home PD; Massi-Benedetti M; Worth R; Cook DB; Heaton A; Alberti KG
    Diabetes Res; 1984 Nov; 1(4):187-93. PubMed ID: 6397293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overnight basal insulin requirements in insulin dependent diabetics.
    Vague P; Moulin JP; Souid J; Lassmann V; Vialettes B
    Diabete Metab; 1983 Dec; 9(4):288-91. PubMed ID: 6365641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
    Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
    Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the endocrine artificial pancreas (GCIIS; Biostator) in heart surgery].
    Calabrese G; Bueti A; Zega G; Bellomo G; Antonella MA; Giombolini A; Tardioli F; Massi-Benedetti M; Palminiello A
    Minerva Med; 1982 Dec; 73(49-50):3509-14. PubMed ID: 7155400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of insulin needs in insulin-dependent diabetics and healthy volunteers under fasting conditions.
    Beyer J; Krause U; Dobronz A; Fuchs B; Delver JR; Wagner R
    Horm Metab Res Suppl; 1990; 24():71-7. PubMed ID: 2272630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal pattern of insulin requirements in insulin-dependent diabetics.
    Mathiesen ER; Rubin P; Sandahl Christiansen J; Aaby Svendsen P; Lauritzen T; Deckert T
    Scand J Clin Lab Invest; 1982 Feb; 42(1):63-8. PubMed ID: 6753093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
    Ratzmann KP; Jutzi E; Albrecht G
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF; Beischer W; Thum C; Clemens AH
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood-sugar-controlled insulin infusion systems for rapid adjustment of insulin-dependent diabetics (author's transl)].
    Beyer J; Becker G; Schulz G; Gaberle E; Wolf E; Hassinger W; Cordes U
    Dtsch Med Wochenschr; 1981 Dec; 106(49):1644-9. PubMed ID: 7030687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.